We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ilika Plc | LSE:IKA | London | Ordinary Share | GB00B608Z994 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 27.00 | 29.00 | 28.00 | 28.00 | 28.00 | 22,361 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 702k | -7.3M | -0.0459 | -6.10 | 44.51M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/5/2022 10:25 | The major market for these is surely not in-body devices, of which there are few eg pacemakers, insulin pumps etc, but smart watches etc, of which there are very many. The company needs to be clearer about which markets its targeting, and how it expects to win business. 'Medical' covers a very wide range of possible applications. | supernumerary | |
13/5/2022 09:24 | Kenjen, you’re wrong, no brand owner is gonna buy a battery from a manufacturer (specifically for medical use) without FDA approval, if they love it they might agree to part fund the approval process but that’d be very rare.. all the risk is with the manufacturer until the tech is approved as safe then one brand owner jumps onboard, then others follow. | phil2003 | |
13/5/2022 08:59 | Then again I’m sitting on a loss so maybe it’s me that’s got the problem :) | kenjen1 | |
13/5/2022 08:53 | Guys ffs! It’s the OEM’s that have to get the approval not the battery company. The product owners get the approval that covers all components of their product. Not approval for each component part!!! I thought you guys were bright! | kenjen1 | |
13/5/2022 08:47 | Was I wrong to predict 65 p for IKA in Nov 21 .But some bought it for 165 so I withdrew to avoid negative feeling in my Dear Colleagues. So its there, not yet out of woods.20/30 | chillu | |
13/5/2022 08:11 | I don't see why they couldn't produce a 99.99% reliable battery, however the testing regimes for in-body medical kit takes ages. No good testing them in rats. They don't live long enough for a proper trial. | horneblower | |
13/5/2022 08:09 | FDA only work to their own process & glacial timings, I had a meeting with them and the MRHA (for a ftse 100) on their own turf and it was like 1940’s Germany… new tech approval will take years. | phil2003 | |
12/5/2022 23:18 | CEO expects to announce further Goliath collaborations over the coming months. He would not be saying that unless things fairly well advanced. Hopefully a further update with the results. | robertspc1 | |
12/5/2022 17:26 | Over the years...dozens. | horneblower | |
12/5/2022 17:25 | Rolled out today by our majority shareholders demand I bet. Either way I don’t think yesterday was as bad as everyone thought. Delays always murder and share price but it will come back, guess it may be a bargain entry point. For some but Im holding, not adding or selling until I see progress or otherwise over the next few months! | kenjen1 | |
12/5/2022 17:23 | Met a lot have you? Pmsl | kenjen1 | |
12/5/2022 17:13 | Hmm. Purdy is not the slipperiest CEO I have met, but he's down there. | horneblower | |
12/5/2022 17:11 | Customers hahahah would be worrying if only 1 :) | kenjen1 | |
12/5/2022 17:07 | So latest video from Graham Purdy Looks like I was correct, they will be selling these batteries beginning of next year, so a 6 month delay! Customer lined up and waiting. Yesterday was awful but I genuinely think the market overreacted! I know I did :) He looks a bit awkward when asked if everthing was ok but as I said, it’s a 6 month delay at worse. | kenjen1 | |
12/5/2022 11:15 | Yes been very secretive about potential car battery technical performance.. and ALL goliath strategic partners have walked away… it doesn’t take a genius to work out whats going on here. | phil2003 | |
12/5/2022 08:52 | No one knows the potential value of Goliath as the company has been very secretive re technical performance etc. But the whole company is valued at £80m after deducting cash. For me that is a very good risk reward opportunity. | robertspc1 | |
12/5/2022 08:32 | irenekent, You can be certain they have run their slide rule over Ilika and declined. Stereax would not be of interest to them. Goliath has little or no IP thus no profitability. | horneblower | |
12/5/2022 00:53 | Why don't Quantum buy Ilika and get a technology thats nearly ready to go? | irenekent | |
11/5/2022 18:42 | I am the first to criticise and boy have the board messed this up! But, I am convinced they have bought themselves more time than they actually need today. They say they will begin selling these batteries financial year h2 23. So that’s April next year at the very latest. We are already a month into financial year 23. No fing way will that deadline be missed. However they will built in serious contingency and I reckon they will be selling these batteries before the end of this year! They still have 23.4 million in cash so no funds needed right now. Gutted that my instinct was correct and a problem had occurred, but come on they are still further ahead than any other SSB company and the market cap is 0.1billion as opposed to the 5.0billion of quantum scape. | kenjen1 | |
11/5/2022 17:14 | Did they confirm the value of the first order , the market will not allow them another issue of shares at silly prices , 10p will be the number , which of course will dilute all holders. | jotoha2 | |
11/5/2022 17:13 | Management have to learn from this. They can't afford any more slip ups and hopefully realise they can't go down the same path with Goliath. The UKBIC will help initially but an existing battery OEM partner needed. Just hope the tech performance gets one on board | robertspc1 | |
11/5/2022 16:14 | Silly sausages.. they’ve lost 2/3rds of the value of their company this year alone. As I’ve said all along, be very wary of ‘jam tomorrow’ grant funded academics, its gonna be a tough fight back from 50p the way they’ve let investors down this year. | phil2003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions